PETTITT JOHN P

SEC source: 0001213900-25-113123 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,833

Underlying: Common Stock · 20,833 shares

Expires 2035-11-17

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ending December 31, 2025.

SEC source: 0001213900-25-098806 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3,125,000

Underlying: Common Stock · 3,125,000 shares

Expires 2035-10-08

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended September 30, 2025.

SEC source: 0001213900-25-061140 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,500,000

Underlying: Common Stock · 2,500,000 shares

Expires 2035-06-30

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended June 30, 2025.

SEC source: 0001213900-26-012800 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 667

Underlying: Common Stock · 667 shares

Expires 2035-03-31

F1 · derivative.exercise_price: On October 24, 2025, the issuer effected a 1-for-750 reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F1 · shares: On October 24, 2025, the issuer effected a 1-for-750 reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ending March 31, 2025.

SEC source: 0001213900-25-026454 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 84,742

Underlying: Common Stock · 67,794 shares

Expires 2029-08-05

F1 · security: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · derivative.exercise_price: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · date: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · derivative.underlying_shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · balance_after: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of March 27, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the decrease in the exercise price of certain securities of the issuer to an effective per share price equal to $0.118 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

SEC source: 0001213900-25-015674 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,948

Underlying: Common Stock · 11,238 shares

Expires 2029-08-05

F1 · security: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of February 18, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the issuance of securities by the issuer at an effective per share price equal to $0.59 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · derivative.exercise_price: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of February 18, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the issuance of securities by the issuer at an effective per share price equal to $0.59 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · date: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of February 18, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the issuance of securities by the issuer at an effective per share price equal to $0.59 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of February 18, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the issuance of securities by the issuer at an effective per share price equal to $0.59 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · derivative.underlying_shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of February 18, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the issuance of securities by the issuer at an effective per share price equal to $0.59 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

F1 · balance_after: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A common stock purchase warrants (the "Warrants") as of February 18, 2025 pursuant to certain anti-dilution provisions in the Warrants that triggered upon the issuance of securities by the issuer at an effective per share price equal to $0.59 on such date, the consequence of which is that (i) the exercise price of the Warrants decreased to such price and (ii) the number of shares of common stock issuable upon exercise of such Warrants proportionally increased, such that the aggregate exercise price of the Warrants, after taking into account such exercise price decrease, remained equal to the aggregate exercise price at the date of issuance of such Warrants.

SEC source: 0001213900-25-001373 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6,667

Underlying: Common Stock · 6,667 shares

Expires 2035-01-01

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended December 31, 2024, and have an exercise price of $1.50 per share, which was the closing price of the issuer's common stock, par value $0.0001 per share, on such date.

SEC source: 0001213900-24-104153 · ownership.xml · derivative · entry 2

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,710

Underlying: Common Stock · 4,851 shares

Expires 2027-02-05

F1 · security: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · security: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · derivative.exercise_price: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · derivative.exercise_price: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F2 · date: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · shares: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · price: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F1 · derivative.underlying_shares: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · derivative.underlying_shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · balance_after: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · balance_after: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

SEC source: 0001213900-24-104153 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,710

Underlying: Common Stock · 4,851 shares

Expires 2029-08-05

F1 · security: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · security: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · derivative.exercise_price: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · derivative.exercise_price: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F2 · date: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · shares: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · price: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F1 · derivative.underlying_shares: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · derivative.underlying_shares: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

F1 · balance_after: On November 18, 2024, the issuer effected a one-for-twenty-five reverse stock split (the "Reverse Stock Split") of the issuer's outstanding shares of common stock, par value $0.0001 per share (the "Common Stock"). The number of shares of Common Stock and prices reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.

F2 · balance_after: This Form 4 is being filed by the reporting person in order to reflect the acquisition of Series A Common Stock Purchase Warrants (the "Series A Warrants") and Series B Common Stock Purchase Warrants (the "Series B Warrants", and collectively with the Series A Warrants, the "Warrants") as of November 26, 2024 pursuant to certain anti-dilution provisions in the Warrants that trigger upon the Reverse Stock Split, the consequence of which is that (i) the exercise prices of the Warrants decrease pursuant to the formula contained in such provisions and (ii) the number of shares of Common Stock issuable upon exercise of the Warrants proportionally increases, such that the aggregate exercise price of each of the Warrants following such adjustments remains equal to the aggregate exercise price of each of such Warrants as of their respective dates of issuance.

SEC source: 0001213900-24-084644 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 64,516

Underlying: Common Stock · 64,516 shares

Expires 2034-09-30

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended September 30, 2024.

SEC source: 0001213900-24-085040 · ownership.xml · derivative · entry 3

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,486

Underlying: Common Stock · 21,486 shares

Expires 2027-02-05

F1 · security: Each of the shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), the Series A Common Stock Purchase Warrants (the "Series A Warrants"), the Series B Common Stock Purchase Warrants (the "Series B Warrants"), and any other securities held by the reporting person that are convertible, exchangeable or exercisable into shares of Common Stock, are subject to the terms and conditions of a lock-up agreement entered into between the issuer (the "Company") and the reporting person, which prevents the offer, sale or other disposition thereof, subject to certain exceptions, for a period of 60 days from the date of the closing of the Company's offering of its securities pursuant to the Company's registration statement on Form S-1, as amended (File No. 333-179133), declared effective by the U.S. Securities and Exchange Commission ("SEC") on August 1, 2024.

F2 · security: This Form 4 amendment is being filed by the reporting person in order to reflect the acquisition by the reporting person of the Series A Warrants and the Series B Warrants on October 1, 2024, the date on which the Company obtained the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants in accordance with Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval"), on which the exercisability of each of the Series A Warrants and the Series B Warrants was conditioned. Accordingly, the dates in Columns 3 and 6 of Table II of the Form 4 filed by the reporting person with the SEC on August 6, 2024 (the "Original Form 4") are hereby amended to October 1, 2024.

F2 · date: This Form 4 amendment is being filed by the reporting person in order to reflect the acquisition by the reporting person of the Series A Warrants and the Series B Warrants on October 1, 2024, the date on which the Company obtained the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants in accordance with Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval"), on which the exercisability of each of the Series A Warrants and the Series B Warrants was conditioned. Accordingly, the dates in Columns 3 and 6 of Table II of the Form 4 filed by the reporting person with the SEC on August 6, 2024 (the "Original Form 4") are hereby amended to October 1, 2024.

F2 · derivative.exercise_date: This Form 4 amendment is being filed by the reporting person in order to reflect the acquisition by the reporting person of the Series A Warrants and the Series B Warrants on October 1, 2024, the date on which the Company obtained the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants in accordance with Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval"), on which the exercisability of each of the Series A Warrants and the Series B Warrants was conditioned. Accordingly, the dates in Columns 3 and 6 of Table II of the Form 4 filed by the reporting person with the SEC on August 6, 2024 (the "Original Form 4") are hereby amended to October 1, 2024.

SEC source: 0001213900-24-085040 · ownership.xml · derivative · entry 2

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 62,772

Underlying: Common Stock · 62,772 shares

Expires 2029-08-05

F1 · security: Each of the shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), the Series A Common Stock Purchase Warrants (the "Series A Warrants"), the Series B Common Stock Purchase Warrants (the "Series B Warrants"), and any other securities held by the reporting person that are convertible, exchangeable or exercisable into shares of Common Stock, are subject to the terms and conditions of a lock-up agreement entered into between the issuer (the "Company") and the reporting person, which prevents the offer, sale or other disposition thereof, subject to certain exceptions, for a period of 60 days from the date of the closing of the Company's offering of its securities pursuant to the Company's registration statement on Form S-1, as amended (File No. 333-179133), declared effective by the U.S. Securities and Exchange Commission ("SEC") on August 1, 2024.

F2 · security: This Form 4 amendment is being filed by the reporting person in order to reflect the acquisition by the reporting person of the Series A Warrants and the Series B Warrants on October 1, 2024, the date on which the Company obtained the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants in accordance with Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval"), on which the exercisability of each of the Series A Warrants and the Series B Warrants was conditioned. Accordingly, the dates in Columns 3 and 6 of Table II of the Form 4 filed by the reporting person with the SEC on August 6, 2024 (the "Original Form 4") are hereby amended to October 1, 2024.

F3 · derivative.exercise_price: This Form 4 amendment is also being filed by the reporting person to amend the exercise price reported in Column 2 of Table II of the Original Form 4 and the number of shares of Common Stock reported in Columns 5, 7 and 9 of Table II of the Original Form 4 to reflect such information as of the date of Stockholder Approval.

F2 · date: This Form 4 amendment is being filed by the reporting person in order to reflect the acquisition by the reporting person of the Series A Warrants and the Series B Warrants on October 1, 2024, the date on which the Company obtained the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants in accordance with Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval"), on which the exercisability of each of the Series A Warrants and the Series B Warrants was conditioned. Accordingly, the dates in Columns 3 and 6 of Table II of the Form 4 filed by the reporting person with the SEC on August 6, 2024 (the "Original Form 4") are hereby amended to October 1, 2024.

F3 · shares: This Form 4 amendment is also being filed by the reporting person to amend the exercise price reported in Column 2 of Table II of the Original Form 4 and the number of shares of Common Stock reported in Columns 5, 7 and 9 of Table II of the Original Form 4 to reflect such information as of the date of Stockholder Approval.

F2 · derivative.exercise_date: This Form 4 amendment is being filed by the reporting person in order to reflect the acquisition by the reporting person of the Series A Warrants and the Series B Warrants on October 1, 2024, the date on which the Company obtained the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants in accordance with Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval"), on which the exercisability of each of the Series A Warrants and the Series B Warrants was conditioned. Accordingly, the dates in Columns 3 and 6 of Table II of the Form 4 filed by the reporting person with the SEC on August 6, 2024 (the "Original Form 4") are hereby amended to October 1, 2024.

F3 · derivative.underlying_shares: This Form 4 amendment is also being filed by the reporting person to amend the exercise price reported in Column 2 of Table II of the Original Form 4 and the number of shares of Common Stock reported in Columns 5, 7 and 9 of Table II of the Original Form 4 to reflect such information as of the date of Stockholder Approval.

F3 · balance_after: This Form 4 amendment is also being filed by the reporting person to amend the exercise price reported in Column 2 of Table II of the Original Form 4 and the number of shares of Common Stock reported in Columns 5, 7 and 9 of Table II of the Original Form 4 to reflect such information as of the date of Stockholder Approval.

SEC source: 0001213900-24-065869 · ownership.xml · derivative · entry 3

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,486

Underlying: Common Stock · 21,486 shares

Expires 2027-02-05

F1 · security: Each of the shares of the issuer's common stock, par value $0.0001 per share (the "Common Stock"), the issuer's Series A Common Stock Purchase Warrants (the "Series A Warrants"), the issuer's Series B Common Stock Purchase Warrants (the "Series B Warrants"), and any other securities of the issuer (the "Company") held by the reporting person that are convertible, exchangeable or exercisable into shares of Common Stock, are subject to the terms and conditions of a lock-up agreement entered into between the Company and the reporting person, which prevents the offer, sale or other disposition thereof, subject to certain exceptions, for a period of 60 days from the date of the closing of the Company's offering of its securities pursuant to the Company's registration statement on Form S-1, as amended (File No. 333-179133), declared effective by the U.S. Securities and Exchange Commission on August 1, 2024.

F3 · derivative.exercise_date: The Series B Warrants are only exercisable on or after the date of Stockholder Approval.

SEC source: 0001213900-24-065869 · ownership.xml · derivative · entry 2

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,486

Underlying: Common Stock · 21,486 shares

Expires 2029-08-05

F1 · security: Each of the shares of the issuer's common stock, par value $0.0001 per share (the "Common Stock"), the issuer's Series A Common Stock Purchase Warrants (the "Series A Warrants"), the issuer's Series B Common Stock Purchase Warrants (the "Series B Warrants"), and any other securities of the issuer (the "Company") held by the reporting person that are convertible, exchangeable or exercisable into shares of Common Stock, are subject to the terms and conditions of a lock-up agreement entered into between the Company and the reporting person, which prevents the offer, sale or other disposition thereof, subject to certain exceptions, for a period of 60 days from the date of the closing of the Company's offering of its securities pursuant to the Company's registration statement on Form S-1, as amended (File No. 333-179133), declared effective by the U.S. Securities and Exchange Commission on August 1, 2024.

F2 · derivative.exercise_date: The Series A Warrants are only exercisable on or after the date on which the Company obtains the approval of its stockholders for the issuance of all shares of Common Stock issuable upon exercise of each of the Series A Warrants and Series B Warrants solely to the extent such approval is required by Rule 5635(d) of The Nasdaq Stock Market LLC (the "Stockholder Approval").

SEC source: 0001213900-24-065869 · ownership.xml · nonDerivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,486

F1 · security: Each of the shares of the issuer's common stock, par value $0.0001 per share (the "Common Stock"), the issuer's Series A Common Stock Purchase Warrants (the "Series A Warrants"), the issuer's Series B Common Stock Purchase Warrants (the "Series B Warrants"), and any other securities of the issuer (the "Company") held by the reporting person that are convertible, exchangeable or exercisable into shares of Common Stock, are subject to the terms and conditions of a lock-up agreement entered into between the Company and the reporting person, which prevents the offer, sale or other disposition thereof, subject to certain exceptions, for a period of 60 days from the date of the closing of the Company's offering of its securities pursuant to the Company's registration statement on Form S-1, as amended (File No. 333-179133), declared effective by the U.S. Securities and Exchange Commission on August 1, 2024.

SEC source: 0001213900-24-085040 · ownership.xml · nonDerivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 21,486

F1 · security: Each of the shares of the Company's common stock, par value $0.0001 per share (the "Common Stock"), the Series A Common Stock Purchase Warrants (the "Series A Warrants"), the Series B Common Stock Purchase Warrants (the "Series B Warrants"), and any other securities held by the reporting person that are convertible, exchangeable or exercisable into shares of Common Stock, are subject to the terms and conditions of a lock-up agreement entered into between the issuer (the "Company") and the reporting person, which prevents the offer, sale or other disposition thereof, subject to certain exceptions, for a period of 60 days from the date of the closing of the Company's offering of its securities pursuant to the Company's registration statement on Form S-1, as amended (File No. 333-179133), declared effective by the U.S. Securities and Exchange Commission ("SEC") on August 1, 2024.

SEC source: 0001213900-24-058031 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 16,393

Underlying: Common Stock · 16,393 shares

Expires 2034-06-30

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended June 30, 2024.

SEC source: 0001213900-24-030819 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,000

Underlying: Common Stock · 10,000 shares

Expires 2034-04-02

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended December 31, 2023.

SEC source: 0001213900-24-005756 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 25,755

Underlying: Common Stock · 5,618 shares

Expires 2034-01-18

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended September 30, 2023.

SEC source: 0001213900-24-005741 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 20,137

Underlying: Common Stock · 9,434 shares

Expires 2034-01-01

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended December 31, 2023, and have an exercise price of $1.06 per share, which was the closing price of the issuer's common stock, par value $0.0001 per share ("Common Stock"), on December 29, 2023.

F2 · balance_after: The number of shares of Common Stock underlying stock options beneficially owned has been decreased by thirty-four from the number of shares underlying stock options reported as beneficially owned in the Form 4 filed by the reporting person on August 10, 2023 in order to correct an inadvertent administrative error in such prior Form 4 to fully reflect the effect on such number of shares due to the issuer's 1-for-20 reverse stock split of outstanding shares of Common Stock on April 21, 2023.

SEC source: 0001213900-23-065815 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,737

Underlying: Common Stock · 3,425 shares

Expires 2033-08-06

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended June 30, 2023, and have an exercise price of $2.92 per share, which was the closing price of the issuer's common stock, par value $0.0001 per share ("Common Stock"), on such date.

F2 · balance_after: On April 21, 2023, the issuer effected a 1-for-20 reverse stock split of its outstanding shares of Common Stock. The number of shares of Common Stock reported on this Form 4 have been adjusted to reflect such reverse stock split as it pertained to the number of shares of Common Stock that the reporting person held immediately following the grant of the stock options.

SEC source: 0001213900-23-027623 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 146,229

Underlying: Common Stock · 66,666 shares

Expires 2033-04-03

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended March 31, 2023, and have an exercise price of $0.15 per share, which was based on the closing price of the issuer's common stock, par value $0.0001 per share, on such date.

SEC source: 0001213900-23-015529 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 79,563

Underlying: Common Stock · 52,632 shares

Expires 2033-02-24

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended December 31, 2022, and have an exercise price of $0.19 per share, which was the closing price of the issuer's common stock, par value $0.0001 per share, on February 23, 2023.

SEC source: 0001213900-22-062275 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,931

Underlying: Common Stock · 13,210 shares

Expires 2032-10-03

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended September 30, 2022, and have an exercise price of $0.757 per share, which was the closing price of the issuer's common stock, par value $0.0001 per share, on such date.

SEC source: 0001213900-22-037530 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,721

Underlying: Common Stock · 9,175 shares

Expires 2032-06-30

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the board of directors of the issuer for the quarter ended June 30, 2022, and have an exercise price of $1.09 per share, which was the closing price of the issuer's common stock, par value $0.0001 per share, on such date.

SEC source: 0001213900-22-018195 · ownership.xml · derivative · entry 1

PETTITT JOHN P · CIK 0001064145 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,546

Underlying: Common Stock · 4,546 shares

Expires 2032-04-01

F1 · shares: The stock options were received as compensation for the reporting person's services as a member of the Board of Directors of the Issuer for the quarter ended March 31, 2022.